Novel Antibodies Targeting the Inflammasome to Treat Neurodegeneration

Time: 2:30 pm
day: Day Two

Details:

  • Discuss how the inflammasome is a promising target in neurodegenerative diseases
  • Learn how Mabylon has identified novel monoclonal antibodies that hold
    promise for the treatment of neurodegeneration

Speakers: